(19)
(11) EP 4 196 107 A1

(12)

(43) Date of publication:
21.06.2023 Bulletin 2023/25

(21) Application number: 21856361.7

(22) Date of filing: 02.08.2021
(51) International Patent Classification (IPC): 
A61K 31/155(2006.01)
A61K 9/20(2006.01)
 A61K 31/4985(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4985; A61K 31/155; A61K 9/2054
 
C-Sets:
  1. A61K 31/4985, A61K 2300/00;
  2. A61K 31/155, A61K 2300/00;
(86) International application number:
PCT/TR2021/050760
(87) International publication number:
WO 2022/035400 (17.02.2022 Gazette 2022/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 11.08.2020 TR 202012601

(71) Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
34460 Sariyer/Istanbul (TR)

(72) Inventors:
  • ATAMAN, Seval
    34460 Sariyer/Istanbul (TR)
  • ULUSOY BOZYEL, Muge
    34460 Sariyer/Istanbul (TR)
  • SUNEL, Fatih
    34460 Sariyer/Istanbul (TR)
  • MUTLU, Onur
    34460 Sariyer/Istanbul (TR)
  • URAZ, Ezel
    34460 Sariyer/Istanbul (TR)
  • AVERBEK, Seda
    34460 Sariyer/Istanbul (TR)

(74) Representative: Sevinç, Erkan 
Istanbul Patent A.S. Plaza-33, Büyükdere Cad. No: 33/16 Sisli
34381 Istanbul
34381 Istanbul (TR)

   


(54) A TABLET FORMULATION COMPRISING SITAGLIPTIN AND METFORMÍN